TYSABRI (natalizumab)

Pages: [1] 2 3 ... 6

Subject / Started by	Replies / Views	Last post
(Abst.) Risk of postpartum disease activity with subcutaneous vs. IV natalizumab in pregnant women w/MS (Abst.) Risk of postpartum disease activity with subcutaneous vs. IV natalizumab in pregnant women w/MS agate · March 01, 2026, 08:42:04 pm From PubMed (March 1, 2026)--"Risk of postpartum disease activity with subcutaneous versus intravenous natalizumab in pregnant w... 0 Replies · 12 Views Started by agate	0 Replies 12 Views	March 01, 2026, 08:42:04 pm by agate
(Abst.) Managing reactivation of MS during treatment w/natalizumab (Abst.) Managing reactivation of MS during treatment w/natalizumab agate · December 20, 2025, 04:01:31 pm From PubMed (December 20, 2025)--"Managing reactivation of multiple sclerosis during treatment with natalizumab":https://pubmed.... 0 Replies · 9 Views Started by agate	0 Replies 9 Views	December 20, 2025, 04:01:31 pm by agate
Tysabri-related PML cases Tysabri-related PML cases agate · March 26, 2017, 01:51:38 pm New data reveal that as of March 6, 2017, there have been 714 confirmed Tysabri-related PML cases worldwide, with 711 of them in... 6 Replies · 960 Views Started by agate	6 Replies 960 Views	August 30, 2025, 09:28:19 pm by agate
(Abst.) Natalizumab for MS [Cochrane Database Sys Rev] (Abst.) Natalizumab for MS [Cochrane Database Sys Rev] agate · August 07, 2025, 07:01:31 am From PubMed (August 7, 2025)--"Natalizumab for multiple sclerosis" (Cochrane Datebase Sys Rev)https://pubmed.ncbi.nlm.nih.gov/40... 0 Replies · 10 Views Started by agate	0 Replies 10 Views	August 07, 2025, 07:01:31 am by agate
Should natalizumab be used despite JC virus positivity? Should natalizumab be used despite JC virus positivity? agate · June 05, 2025, 08:51:39 pm From Multiple Sclerosis Journal (May 30, 2025)--"Commentary: Should natalizumab be used despite JC virus positivity?"https://jou... 0 Replies · 15131 Views Started by agate	0 Replies 15131 Views	June 05, 2025, 08:51:39 pm by agate
(Abst.) Subq administration of natalizumab can lead to lower drug concentrations compared to IV (Abst.) Subq administration of natalizumab can lead to lower drug concentrations compared to IV agate · August 05, 2024, 02:59:55 pm From PubMed (August 5, 2024)--"Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intr... 0 Replies · 485 Views Started by agate	0 Replies 485 Views	August 05, 2024, 02:59:55 pm by agate
(Abst.) Altered lymphocyte profiles and [shingles] infections in MS patients on natalizumab (Abst.) Altered lymphocyte profiles and [shingles] infections in MS patients on natalizumab agate · June 17, 2024, 01:52:18 pm It looks as if it's important to be vaccinated against shingles if you're going to take Tysabri.From PubMed (June 17, 2024)--"Al... 0 Replies · 357 Views Started by agate	0 Replies 357 Views	June 17, 2024, 01:52:18 pm by agate
Fatigue and processing speed in PwMS treated with Tysabri or Rituxan Fatigue and processing speed in PwMS treated with Tysabri or Rituxan agate · June 03, 2024, 07:40:21 am From Multiple Sclerosis Journal--Experimental, Translational, and Clinical (May 26, 2024)--"A comparative study of fatigue and p... 0 Replies · 448 Views Started by agate	0 Replies 448 Views	June 03, 2024, 07:40:21 am by agate
(Abst.) Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy (Abst.) Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy agate · December 22, 2023, 02:22:50 pm From PubMed (December 22, 2023)—“Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy”:http... 0 Replies · 364 Views Started by agate	0 Replies 364 Views	December 22, 2023, 02:22:50 pm by agate
Tysabri biosimilar for relapsing MS under FDA review Tysabri biosimilar for relapsing MS under FDA review agate · July 27, 2022, 08:12:52 pm A biosimilar isn't quite a bioequivalent but biosimilars of many costly drugs are being developed because they're apparently clo... 2 Replies · 558 Views Started by agate	2 Replies 558 Views	August 30, 2023, 09:19:50 pm by agate
(Abst.) Developing a model of care for home infusions of Tysabri... (Abst.) Developing a model of care for home infusions of Tysabri... agate · November 08, 2019, 08:48:05 am Some nursing researchers are studying developing a way to make home infusions of Tysabri possible for people with MS.From PubMed... 4 Replies · 1204 Views Started by agate	4 Replies 1204 Views	May 19, 2023, 09:35:08 pm by agate
Biogen Seeks preliminary injunction in case against Sandoz Biogen Seeks preliminary injunction in case against Sandoz agate · October 28, 2022, 09:38:35 pm From Big Molecule Watch (October 27, 2022)--"Biogen Seeks a Preliminary Injunction in Natalizumab BPCIA Case against Sandoz":htt... 0 Replies · 350 Views Started by agate	0 Replies 350 Views	October 28, 2022, 09:38:35 pm by agate
(AAN) PML risk cut by extending Tysabri dosing interval (AAN) PML risk cut by extending Tysabri dosing interval agate · April 27, 2018, 02:23:48 pm From Multiple Sclerosis News Today, April 23, 2018--"#AAN2018: PML Risk Cut by Extending Tysabri Dosing Interval":https://multip... 5 Replies · 703 Views Started by agate	5 Replies 703 Views	June 05, 2022, 04:37:54 pm by agate
(ACTRIMS) PML incidence rates in US patients treated w/natalizumab (ACTRIMS) PML incidence rates in US patients treated w/natalizumab agate · February 28, 2022, 09:03:23 pm Abstract of a poster presentation at the annual ACTRIMS conference held in West Palm Beach, FL, February 24-26, 2022--"PML incid... 0 Replies · 288 Views Started by agate	0 Replies 288 Views	February 28, 2022, 09:03:23 pm by agate
(Abst.) MS disease activity and disability after discontinuing Tysabri for pregnancy (Abst.) MS disease activity and disability after discontinuing Tysabri for pregnancy agate · January 25, 2022, 09:03:25 pm From JAMA Network Open (January 4, 2022)--"Multiple sclerosis disease activity and disability following discontinuation of natal... 0 Replies · 433 Views Started by agate	0 Replies 433 Views	January 25, 2022, 09:03:25 pm by agate
JCV mutations may predict Tysabri-related PML JCV mutations may predict Tysabri-related PML agate · October 04, 2021, 04:39:39 pm From Multiple Sclerosis News Today (October 4, 2021)--"JCV mutations may predict rare brain infection linked to Tysabri":https:/... 0 Replies · 294 Views Started by agate	0 Replies 294 Views	October 04, 2021, 04:39:39 pm by agate
European Commission grants marketing authorization for subcutaneous Tysabri European Commission grants marketing authorization for subcutaneous Tysabri agate · April 07, 2021, 08:38:23 pm Tysabri may soon be available for subcutaneous administration, eliminating the need for trips to infusion centers, according to ... 1 Replies · 537 Views Started by agate	1 Replies 537 Views	May 06, 2021, 09:04:27 pm by agate
(Abst.) PML and the spectrum of JC virus-related disease (Abst.) PML and the spectrum of JC virus-related disease agate · November 22, 2020, 11:44:41 am From PubMed (November 22, 2020)--"Progressive multifocal leucoencephalopathy and the spectrum of JC virus-related disease," an a... 0 Replies · 287 Views Started by agate	0 Replies 287 Views	November 22, 2020, 11:44:41 am by agate
(Abst.) Tysabri better than Gilenya in achieving "no evidence of disease activity" (Abst.) Tysabri better than Gilenya in achieving "no evidence of disease activity" agate · November 10, 2020, 08:38:32 pm From PubMed (October 30, 2020), "BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active ... 0 Replies · 377 Views Started by agate	0 Replies 377 Views	November 10, 2020, 08:38:32 pm by agate
(Abst.) Fatal COVID-19 in an MS patient on natalizumab... (Abst.) Fatal COVID-19 in an MS patient on natalizumab... agate · August 29, 2020, 03:19:57 pm From PubMed (August 29, 2020)--"Fatal COVID-19 in an MS patient on natalizumab: A case report":https://pubmed.ncbi.nlm.nih.gov/3... 0 Replies · 274 Views Started by agate	0 Replies 274 Views	August 29, 2020, 03:19:57 pm by agate

Pages: [1] 2 3 ... 6

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

MS Speaks